The latest Neurology Research Review has been published with a special focus on Multiple Sclerosis. This issue is reviewed by Dr Jennifer Pereria, Specialist MS Neurologist at Auckland.
In this issue, researchers in Spain report that MS patients taking anti-CD20 treatments such as ocrelizumab and rituximab, might be at increased risk for COVID-19.
Other highlights include:
- Trial reports positive results with stem cell transplantation in patients with active and progressive MS
- Is there an association between concussion in adolescence and future MS diagnosis?
- Italian investigators suggest an association between lymphocyte count and dimethyl efficacy
- Study finds that amantadine, modafinil and methylphenidate do not improve fatigue associated with MS
This is a newsletter for health professionals. If you wish to be added to the database to receive this directly you can email Research Review Limited: email@example.com or subscribe via their website directly www.researchreview.co.nz.